Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India.  The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own onsite clinical research coordinators to each site, prides itself on running ethical trials and delivering data quality and data integrity to its clients. Please click here to read the full article


IMPAX Laboratories, Inc. Sacks 25% Of R&D Staff In Reorg

Off With Their Heads! s Favorite CEOs Who Got The Axe In 2014

Novartis AG Quietly Leases Large Space In Philadelphia

GlaxoSmithKline Refocusing And Reshaping Oncology R&D

Novartis AG Eliminates Another 75 Jobs

Deal-Starved Perrigo Company In Exclusive Talks To Buy $5 Billion+ Omega Pharma NV

How To Build A Real Patient-Centered Pharmaceutical Company

Hundreds Of New Jobs Coming To Virginia As Snaps Up Boehringer Ingelheim Corporation's Old Plant

Novo Nordisk A/S Commits $130 Million In Diabetes Research In Denmark

AbbVie Might Go Shopping Again Despite Shire Breakup, Say Company Execs

Ebola Resistance In Mice: Why Some People Survive Disease, University of Washington Reveals

Could Copper Prevent Spread Of Ebola? University of Southampton Study

IQs On The Up: Scientists Show We Are Getting Smarter

Novel Treatment To Decrease Craving In Alcoholics Identified, Study

Can Parents Make Their Kids Smarter? Study

SF's Billion Dollar Biotech FibroGen, Inc. Sets Terms For $124 Million IPO

Citi: Gilead Sciences, Inc. Sees Blockbuster First Weeks Of Harvoni Launch

SF Startup Reels In $26.5 Million

AVANIR Pharmaceuticals Gives Suitors Two Big Reasons To Bid

FDA Panel Backs Daiichi Sankyo, Inc.'s New A-Fib Drug Savaysa

Profectus BioSciences, Inc. Nabs $9.5 Million Government Grant

Oragenics, Inc. CEO Resigns; Hunt For New Chief Begins

Sanofi Approached AstraZeneca PLC's For CEO Role

Sanofi: What About Genzyme Corporation?

Sanofi Ousts CEO After Clash Over Strategy

The Reasons Why Remains The Best CEO To Head Sarepta Therapeutics

Under Immense Pressure, Amgen Outlines Strategy

Amgen, Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst

Sanofi CEO Wrote To Board Asking To Keep His Job

New Tax Rules Won???t Deter Pfizer From Bidding U.S. Goodbye: CEO

AstraZeneca PLC Wins FDA Approval For Two-In-One Diabetes Pill

Express Scripts Inc. Says AbbVie's Drug Could Displace Gilead Sciences, Inc.'s Sovaldi On Formulary

When Will Biosimilars Impact The U.S. Market?

Boston???s Rhythm Withdraws $86 Million IPO Citing Acquisition Agreement With Actavis

Abbott Laboratories Pays $250 Million For Menlo Park Startup Topera

Chimerix, Inc. To Raise $105 Million To Finance Ebola Drug Trials

Cipla Ltd. Asks Government To Revoke Five Patents Held By Novartis AG

Cowen: Amgen???s Plans Are ???Music To Our Ears"

Arena Pharmaceuticals, Inc. Skimps On Data Disclosure From Weight-Loss Combo Study: Analyst

Dear Sanofi: Firing CEO Was A Huge Mistake

Amgen Now Expects Job Cuts To Exceed 2,900

Smith & Nephew Inc. CEO Won't Comment On Sanofi Job

Novo Nordisk A/S To Hire 90 In New Hampshire

Bayer AG Hunts For More Deals After Bulking Up Consumer Care

Bristol-Myers Squibb Company's Opdivo Wows In Phase 2 Lung Cancer Study

FortuneRock Raises $24 Million for Protein Drug Development

Novo Nordisk A/S More Mindful On Timing Of U.S. Tresiba Launch

Saliva May Reveal Deadly Diseases Early Enough To Treat Them, University of California, Los Angeles (UCLA) Scientists Report

Pfizer Wins FDA Accelerated Approval For Meningitis Vaccine

Certain Skull Shapes And Other Science Behind Carrying A Tune

Synthetic Milk Could Be In Your Fridge By 2017, Reveals

Dozens Of Genes Associated With Autism In New Research, University of California, San Francisco (UCSF) Reveals

Does Having Children Make Us Any Happier? Study

Contamination Likely Explains "Food Genes In Blood" Claim, University of Michigan Study

Sleeping With More Women Reduces Prostate Cancer Risk, University Of Montreal Study

3 Daily Servings Of Milk Linked To Higher Mortality In Women, Uppsala Universitet Study

Breathe Easier: Get Your Vitamin D, Tel Aviv University Study

Is Violent Crime In Some People's Genes? Karolinska Institute Study

Mushroom Extract, AHCC, Helpful In Treating HPV, University of Texas Health Science Center Research Shows

BioPharm Executive: 5 Reasons To Hate Biotech

Johnson & Johnson Launches Shanghai R&D Hub And Announces New Alliances

MA BioPharma Aileron Therapeutics Locks In A Total Of $48 Million

Ampio Pharmaceuticals, Inc. Could Have A Blockbuster Fourth Quarter, Says Citi

Cara Therapeutics, Inc. Touts Positive Data From New Opiod Pain Drug Trial

DATATRAK International, Inc. Bringing 85 New Jobs To Chicago

Amgen's Exit: Where Will All Those Scientists Go?

Xcovery Raises $20 Million Through Equity Investment From China's

The Leukemia & Lymphoma Society Awards $15.6 Million To Help Advance Research From Lab To Clinic

Sanofi Mulls Firing CEO

The 14 Best-Performing CEOs In Biotech

Novartis AG Expects New Heart Failure Drug As "Multi-Blockbuster"

Ebola Epidemic Unlikely But Not Impossible, Says Immunovaccine Inc. CEO

Cesca Therapeutics Hunts For A New CEO

Laboratory And Health Technology Co., Medytox Solutions, Inc., Names Seamus Lagan New CEO

FDA Staff Recommends Limited Use Of Daiichi Sankyo, Inc.'s Blood Thinner Edoxaban

Eli Lilly, Boehringer Mannheim Corporation Revise Terms Of Diabetes Drugs Alliance

Swiss Test GlaxoSmithKline Ebola Vaccine In Healthy Volunteers Going To Africa

Xencor Regains All Rights From Amgen To Rare AutoImmune Disease Drug, Dumps Arthritis Hopes

Don???t Bet On Stinginess To Keep Stress Low, Queensland University of Technology Study

Tea And Citrus Products Could Lower Ovarian Cancer Risk, New University of East Anglia Research Finds

Manly Men Are Not Always the Best Choice For Partners, Study

Gut Bacteria Byproduct Impacts Heart Failure, Cleveland Clinic Research Shows

Diet Soda Vs. Regular Soda: Is One Worse For You Than The Other?

Amgen Tells Analysts It Will Improve Margins 15% By Axing 4,000 Jobs

Bristol-Myers Squibb Company Forges $475 Million Pact For Rights To f-Star's Cancer Drug

Receptos Soars As Bowel Disorder Drug Meets Phase 2 Goals

Amgen, Ono Pharmaceutical Company, Ltd., Sanofi Team Up With Academia On Proteins Project

Judge Slashes $9 Billion Award Vs Eli Lilly, Takeda Pharmaceutical Co. Ltd. In Actos Lawsuit By 99 Percent

Luye Pharma Pays $390 Million For Remaining 42% Of Beijing Jialin Pharma

Cerulean Pharma Inc. CEO Steps Down

Paragon Bioservices Grabs $13 Million

ImevaX Secures EUR 7.5 Million In Series A Financing To Develop Highly Specific Vaccine Against Helicobacter Pylori Infections

Valeant: We Will Bump Allergan Inc. Offer To $200 A Share

Merck & Co. Execs ???Downplaying??? Gilead Sciences, Inc.'s Harvoni Competitor, Says Analyst

Bio Venture Specialists Banks $235 Million Life Sciences Fund

AstraZeneca PLC May Walk Away From Antibiotics R&D

Novartis AG Sells Flu Vaccine Business For $275 Million To CSL Limited

Slowing The Biological Clock, Tel Aviv University Study

Synthetic Genomics, Inc. Appoints MBA As Chief Executive Officer

TxCell Achieves Positive Results For Col-Treg In A Model Of Autoimmune Uveitis

Ebola Clinical Trials: Big Name Players In The Ebola Race

First Atlas Of Body Clock Shows How Timing Affects Medication, University of Pennsylvania Study

Cocoa May Reverse Age-Related Memory Decline, Study

Whites Of Their Eyes: Infants Respond To Social Cues From Sclera, University of Virginia Study

Ebola???s Evolutionary Roots More Ancient Than Previously Thought, University at Buffalo Study

Mental Health Disorders Double Heart Disease, Stroke Risk, Study

Amgen Lays Off 274 Employees As Part Of Its Exit From Washington State

Is Sarepta Therapeutics Short Of Cash?

High Drug Prices Could Increase Industry Innovation

For A New Grad Interested In A Drug R&D Job, Is Biotech Better Than Big Pharma?

Citi: Sarepta Therapeutics Will See Competition, Concern Over FDA Delay

Sarepta Therapeutics Tanks As FDA Seeks Further Data On Eteplirsen; Stock Down 32.47% At Market Close (Oct. 27, 2014)

Bay Area's Coherus Biosciences Sets Terms For $85 Million IPO

Pain Therapeutics Tanks As Pfizer Walks Away From Remoxy® Deal

MA Startup Syros Pharmaceuticals Banks $53 Million Series B

Zogenix, Inc. Snags U.K.-Based Brabant Pharma In $35 Million Cash-Stock Deal

pSivida Corp Pockets $25 Million Milestone Payment

CTI BioPharma Grabs Exclusive Worldwide Rights To Tosedostat

Alchemia Shares Plummet On Failed Colorectal Cancer Trial

Akebia Therapeutics, Inc.'s Lead Drug AKB-6548 Succeeds In Mid-Stage Trial

Novo Nordisk A/S Receives U.S. Subpoena Related To Danish Factory

Merck & Co. Scores Another Breakthrough For KEYTRUDA®

Eli Lilly And Luminex Exclusive: Straight Talk From Career Experts On How To Get Hired

Pfizer's $11 Billion Buyback Dims Prospects Of AstraZeneca PLC Bid

Clarus Ventures Adds And To Cambridge Office


    Read more..